AU:ALA Stock Latest News
Company AnnouncementsArovella doses first patient in phase 1 trial of off-the-shelf cell therapy ALA-1015d ago
Company AnnouncementsArovella Advances Off-the-Shelf CAR-iNKT Trials as Cash Position Strengthens1w ago
Company AnnouncementsArovella boosts off-the-shelf CAR-iNKT trial readiness with second clinical batch release3w ago- Company AnnouncementsArovella Showcases iNKT Cell Therapy Platform at Major Cell and Gene Meeting3w ago
Company AnnouncementsArovella Nears First Patient Dosing in Pivotal ALA-101 Cell Therapy Trial1M ago
Company AnnouncementsArovella Deepens ESG Commitment Ahead of Australia’s Sustainability Rules1M agoCompany AnnouncementsArovella Sets Hybrid 2026 AGM and Shifts to Default Digital Communications1M ago
Company AnnouncementsArovella lodges 2026 corporate governance statement and Appendix 4G2M ago
Company AnnouncementsArovella Narrows Annual Loss as Net Tangible Assets Per Share Fall2M ago
Company AnnouncementsArovella Issues 9.7 Million Unquoted Options Under Employee Incentive Scheme2M ago
Company AnnouncementsArovella outlines strategy and ALA-101 trial timeline in investor webinar2M ago
Company AnnouncementsArovella plans investor webinar ahead of first-in-human ALA-101 trial2M ago
- Company AnnouncementsArovella Therapeutics Seeks ASX Quotation for Additional Shares4M ago
Company AnnouncementsArovella Director Increases Indirect Stake with On-Market Share Purchase4M ago
Company AnnouncementsArovella strengthens clinical team ahead of first ALA-101 human trial4M ago- Company AnnouncementsArovella options lapse, trimming potential dilution in capital structure5M ago
Company AnnouncementsArovella Therapeutics Options Lapse Clarifies Capital Structure5M agoCompany AnnouncementsArovella Therapeutics Reports Director Andrew Nash’s Departure With No Security Interests5M ago
Company AnnouncementsArovella Highlights Solid-Tumour CAR-iNKT Advances at Global Cell Therapy Meeting5M ago
